10 July 2021: Database Analysis
Outcomes of Targeted Temperature Management for In-Hospital and Out-Of-Hospital Cardiac Arrest: A Matched Case-Control Study Using the National Database of Taiwan Network of Targeted Temperature Management for Cardiac Arrest (TIMECARD) Registry
Yu-san Chien 12BCDEF , Min-Shan Tsai 3B , Chien-Hua Huang 3A , Chih-Hung Lai 4AB , Wei-Chun Huang 5A , Lung Chan 6AB , Li-Kuo Kuo 12ADF*DOI: 10.12659/MSM.931203
Med Sci Monit 2021; 27:e931203
Table 1 Baseline characteristics and pre-existing comorbidities of patients with IHCA and OHCA receiving targeted temperature.
| IHCA | N=103 | OHCA | N=103 | P value | |
|---|---|---|---|---|---|
| 67 | 65.0% | 67 | 65.0% | 1.000 | |
| 71.5 | 22.9 | 70.1 | 23.0 | 0.874 | |
| 1 | 1 | 1 | 1 | 0.580 | |
| Diabetes mellitus, N (%) | 53 | 51.5% | 46 | 44.7% | 0.329 |
| Hypertension, N (%) | 61 | 59.2% | 63 | 61.2% | 0.776 |
| Coronary artery disease, N (%) | 25 | 24.3% | 33 | 32.0% | 0.215 |
| Heart failure, N (%) | 31 | 30.1% | 27 | 26.2% | 0.535 |
| Arrhythmia, N (%) | 18 | 17.5% | 10 | 9.7% | 0.154 |
| Chronic lung disease, N (%) | 13 | 12.6% | 17 | 16.5% | 0.429 |
| Chronic kidney disease, N (%) | 38 | 36.9% | 25 | 24.3% | 0.049 |
| End-stage renal disease, N (%) | 17 | 16.5% | 12 | 11.7% | 0.317 |
| Liver cirrhosis, N (%) | 3 | 2.9% | 3 | 2.9% | 1.000 |
| Cerebrovascular disease, N (%) | 9 | 8.7% | 22 | 21.4% | 0.018 |
| Hyperlipidemia, N (%) | 23 | 22.3% | 20 | 19.4% | 0.607 |
| Active malignancy, N (%) | 24 | 23.3% | 18 | 17.5% | 0.299 |
| 4 | 3 | 5 | 3 | 0.830 | |
| 0–2, N (%) | 17 | 16.5% | 17 | 16.5% | 1.000 |
| 3–4, N (%) | 35 | 34.0% | 34 | 33.0% | 1.000 |
| ≥5, N (%) | 51 | 49.5% | 52 | 50.5% | 1.000 |
| IHCA – in-hospital cardiac arrest; OHCA – out-of-hospital cardiac arrest; CPC – cerebral performance category; IQR – interquartile range. | |||||